What is the equity of Novan this year?
Novan has equity of 4.61 M USD this year.
Novan Equity 2025
Novan Equity
4.61 M USD
Ticker
NOVN
ISIN
US66988N1063
WKN
A2AR9U
In 2025, Novan's equity was 4.61 M USD, a 0% increase from the 0 USD equity in the previous year.
Novan Aktienanalyse
What does Novan do?
Novan Inc is a US biotechnology company specializing in the development of therapy and diagnostic products. The company was founded in 2006 and is headquartered in Morrisville, North Carolina. History: Novan was founded by immunologist and dermatologist John M. Newsome, who serves as the company's scientific director. Newsome established the company with the goal of developing new methods for treating skin diseases such as acne, eczema, and psoriatic arthritis. Newsome and his team began their research at the University of North Carolina, where they modified an innovative drug delivery technique to more effectively exploit the molecular properties of medications. Business model: Novan is a biopharmaceutical company focused on the development of therapy and diagnostic products for dermatological conditions. The company utilizes an innovative approach to optimize drug delivery through targeted administration, offering significant advantages over conventional methods of treating skin diseases. Novan's business model combines research, development, and marketing of therapy and diagnostic products. Industries: The company is divided into three main branches: Novan Therapeutics, Novan Technology, and Nitricil. 1. Novan Therapeutics: This division focuses on developing therapeutic products for dermatological conditions. The company utilizes a novel technology applied through ointments and creams to deliver active ingredients deep into the skin, resulting in improved outcomes. 2. Novan Technology: Novan Technology encompasses the company's research area, where the latest scientific advancements in molecular medicine are explored. This division is instrumental in the development of new compounds and therapies, ensuring Novan remains at the forefront of medical research. 3. Nitricil: Nitricil is an oxygen delivery method developed by Novan, capable of achieving high oxygen concentrations in surrounding tissues. This technology is employed for inflammation treatment and enhancing wound healing. Products: Novan has launched several products, including: 1. SB206: A cream for the treatment of molluscum contagiosum, a viral skin infection primarily occurring in children. 2. SB204: A cream for acne treatment, based on salicylic acid and benzoyl peroxide. 3. SEB-003: An injection in late-stage clinical trials for the treatment of pain associated with knee osteoarthritis. Novan's products can be prescribed by dermatologists and other medical professionals and are available in the United States. Conclusion: Novan Inc is a global leader in the field of molecular medicine and dermatological therapies. The company leads the industry with innovative technologies and products, aiming to improve the lives of patients worldwide. Through the development of new compounds and therapies, Novan contributes to helping individuals with skin problems, ultimately enhancing the lives of millions of people around the world. Novan ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Novan's Equity
Novan's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Novan's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Novan's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Novan's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Novan’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Novan stock
What was the equity of Novan compared to the previous year?
The equity of Novan has increased/decreased by 0% decreased compared to the previous year.
What impact does a high equity have on investors of Novan?
A high equity is advantageous for investors of Novan as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Novan?
A low equity can be a risk for investors of Novan, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Novan affect the company?
An increase in equity of Novan can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Novan affect the company?
A reduction in equity of Novan can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Novan?
Some factors that can affect the equity of Novan include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Novan so important for investors?
The equity of Novan is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Novan take to change the equity?
To change equity, Novan can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Novan pay?
Over the past 12 months, Novan paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Novan is expected to pay a dividend of 0 USD.
What is the dividend yield of Novan?
The current dividend yield of Novan is .
When does Novan pay dividends?
Novan pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Novan?
Novan paid dividends every year for the past 0 years.
What is the dividend of Novan?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Novan located?
Novan is assigned to the 'Health' sector.
Wann musste ich die Aktien von Novan kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Novan from 1/18/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/18/2025.
When did Novan pay the last dividend?
The last dividend was paid out on 1/18/2025.
What was the dividend of Novan in the year 2024?
In the year 2024, Novan distributed 0 USD as dividends.
In which currency does Novan pay out the dividend?
The dividends of Novan are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Novan
Our stock analysis for Novan Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novan Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
